Protection against malaria through RTS, S/AS01 vaccines is through the induction of high levels of both anti-CSP antibodies and CD4 T cells expressing IL-2, TNF, IFN- and the co-stimulatory marker CD40L [20,21]. The gene discussed is IFNA1; the disease is malaria.